Amanta Healthcare IPO is a book-built issue worth ₹126.00 crore, consisting entirely of a fresh issue of 1.00 crore equity shares.
The IPO subscription will open on September 1, 2025, and close on September 3, 2025. The basis of allotment is likely to be finalized on September 4, 2025, while the shares are proposed to be listed on BSE and NSE with a tentative listing date of September 9, 2025.
The price band for the IPO has been fixed at ₹120 to ₹126 per share, with a lot size of 119 shares. For retail investors, the minimum investment required is ₹14,994 (119 shares at the upper price band). For Non-Institutional Investors (NIIs), the requirement is 14 lots (1,666 shares) worth ₹2,09,916 for sNII and 67 lots (7,973 shares) worth ₹10,04,598 for bNII.
Amanta Healthcare IPO Details
| General | Detail |
|---|---|
| IPO Date | September 1, 2025 to September 3, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | ₹120 to ₹126 per share |
| Lot Size | 119 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 1,00,00,000 shares (aggregating up to ₹126.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 2,88,29,351 shares |
| Share Holding Post Issue | 3,88,29,351 shares |
Amanta Healthcare IPO Date
The Amanta Healthcare IPO will open for subscription on September 1, 2025, and close on September 3, 2025.
| IPO Timeline | Date |
|---|---|
| IPO Open Date | Mon, Sep 1, 2025 |
| IPO Close Date | Wed, Sep 3, 2025 |
| Tentative Allotment | Thu, Sep 4, 2025 |
| Initiation of Refunds | Mon, Sep 8, 2025 |
| Credit of Shares to Demat | Mon, Sep 8, 2025 |
| Tentative Listing Date | Tue, Sep 9, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on September 3, 2025 |
Amanta Healthcare IPO Lot Size
Investors can place bids starting with a minimum of 119 shares and in multiples thereof. The table below outlines the minimum and maximum investment requirements for Retail Individual Investors and High Net-Worth Individuals (HNI) in terms of shares and investment value.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 119 | ₹14,994 |
| Retail (Max) | 13 | 1,547 | ₹1,94,922 |
| S-HNI (Min) | 14 | 1,666 | ₹2,09,916 |
| S-HNI (Max) | 66 | 7,854 | ₹9,89,604 |
| B-HNI (Min) | 67 | 7,973 | ₹10,04,598 |
Amanta Healthcare IPO Promoter Holding
The promoters of Amanta Healthcare are Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel, and Milcent Appliances Private Limited.
| Share Holding Pre Issue | 85.60% |
| Share Holding Post Issue | 63.56% |
Note: Equity dilution will be calculated as the difference between the shareholding percentage before the issue (Pre-Issue) and the shareholding percentage after the issue (Post-Issue).
Amanta Healthcare IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50.00% of the Net Issue |
| Retail Shares Offered | Not less than 35.00% of the Net Issue |
| NII Shares Offered | Not less than 15.00% of the Net Issue |
About Amanta Healthcare IPO
Amanta Healthcare Ltd., established with a vision to deliver world-class pharmaceutical solutions, has emerged as a leading manufacturer and exporter of sterile injectables and parenteral formulations. The company specializes in Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs), catering to hospitals, clinics, and healthcare institutions across domestic and international markets. Over the years, Amanta Healthcare has expanded its presence in more than 40 countries, gaining recognition for quality, reliability, and innovation.
Read More
The ownership and promoter team includes Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel, and Milcent Appliances Private Limited, who have played a key role in driving growth and innovation. With state-of-the-art manufacturing facilities in Gujarat, the company is certified by leading regulatory authorities and complies with WHO-GMP standards. Its USP lies in offering high-quality, affordable, and safe healthcare solutions supported by strong R&D capabilities.
Today, Amanta Healthcare stands as a trusted brand in the healthcare industry, backed by its experienced promoter group and skilled workforce. The launch of The Amanta Healthcare IPO marks a strategic step to raise funds for business expansion, strengthen its product pipeline, and enhance market visibility. Investors view The Amanta Healthcare IPO as an opportunity to participate in a growing pharmaceutical company that continues to focus on innovation and global standards.
Company Products
- Large Volume Parenterals (LVPs) in bottles and bags.
- Small Volume Parenterals (SVPs) in vials and ampoules.
- Specialized sterile injectables for hospitals and medical institutions.
- Nutritional and electrolyte solutions to support patient care.
- Export-focused product lines approved in regulated markets.
Company Strengths
- Strong presence in domestic and international markets.
- Backed by an experienced promoter team with proven expertise.
- WHO-GMP certified facilities with advanced quality systems.
- Wide product portfolio covering multiple therapeutic segments.
- Focus on affordability and accessibility in healthcare.
- Robust research and development for new formulations.
- Expanding export footprint in 40+ countries.
Competitors of Anlon Healthcare Ltd.
- Baxter India – a global leader in IV solutions.
- Claris Lifesciences – strong presence in injectables.
- Fresenius Kabi – multinational competitor in parenterals.
- B Braun – known for LVPs and medical solutions.
- Aculife Healthcare – domestic rival in IV fluids and injectables.
Company Financials
Amanta Healthcare Ltd. Financial Information
Amanta Healthcare Ltd. reported a 2% decline in revenue, while its Profit After Tax (PAT) surged by 189% between the financial years ending March 31, 2024, and March 31, 2025.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 381.76 | 352.12 | 374.06 |
| Total Income | 276.09 | 281.61 | 262.70 |
| Profit After Tax | 10.50 | 3.63 | -2.11 |
| EBITDA | 61.05 | 58.76 | 56.31 |
| Net Worth | 96.39 | 66.29 | 62.88 |
| Reserves and Surplus | 67.56 | 39.46 | 36.05 |
| Total Borrowing | 195.00 | 205.23 | 215.66 |
| Amount in ₹ Crore | |||
Key Performance Indicator (KPI)
The estimated market capitalization of The Amanta Healthcare IPO is ₹489.25 crore.
| KPI | Values |
|---|---|
| ROE | 12.42% |
| ROCE | 13.72% |
| Debt/Equity | 2.02 |
| RoNW | 10.89% |
| PAT Margin | 3.86% |
| EBITDA Margin | 22.11% |
| Price to Book Value | 3.77 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 3.64 | 2.70 |
| P/E (x) | 34.59 | 46.59 |
- Note: The Pre-IPO Earnings Per Share (EPS) is derived from the pre-issue shareholding as disclosed in the Red Herring Prospectus (RHP) and the latest financial year earnings up to March 31, 2025. The Post-Issue EPS is calculated on the basis of the post-issue shareholding and the annualized FY 2025 earnings as presented in the RHP.
Objects of the Issue
The Amanta Healthcare IPO proposes to utilize the net proceeds from the issue for the following objectives:
| S.No. | Objects of the Issue | Expected Amount (₹ in crores) |
|---|---|---|
| 1 | Funding capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat | 70.00 |
| 2 | Funding capital expenditure requirements towards civil construction work, purchase of equipment, plant and machinery for setting up new manufacturing line for SVP at Hariyala, Kheda, Gujarat | 30.13 |
| 3 | General corporate purposes |
Amanta Healthcare IPO Contact Details
Amanta Healthcare Ltd. Contact Details
- Amanta Healthcare Ltd.
8th Floor, Shaligram Corporates
C.J. Marg
Ambli,
Ahmedabad, Gujarat, 380058 - Phone: 079 67777600
- Email: cs@amanta.co.in
- Website: https://www.amanta.co.in/
Amanta Healthcare IPO Registrar
- Phone: +91-22-4918 6270
- Email: amantahealthcare.ipo@linkintime.co.in
- Website: https://linkintime.co.in/Initial_Offer/public-issues.html
- Total issue size: ₹126.00 crore
- Fresh issue: ₹126.00 crore (1.00 crore shares)
- Offer for Sale (OFS): Nil
- Opening Date: September 1, 2025
- Closing Date: September 3, 2025
- Price band: ₹120 to ₹126 per share
- Lot size: 119 shares
- Minimum investment (Retail): ₹14,994
- Minimum investment (sNII): ₹2,09,916 for 14 lots (1,666 shares)
- Minimum investment (bNII): ₹10,04,598 for 67 lots (7,973 shares)
- Allotment Date: September 4, 2025 (Tentative)
- Refunds Initiation: September 5, 2025
- Credit to Demat: September 5, 2025
- Listing Date: September 9, 2025 (Tentative)
- Exchanges: BSE and NSE
- Revenue: Declined by 2% (FY24–FY25)
- PAT: Increased by 189% (FY24–FY25)
- Market Capitalization post IPO: ₹489.25 crore
- Bhavesh Patel
- Vishal Patel
- Jayshreeben Patel
- Jitendra Kumar Patel
- Milcent Appliances Private Limited
- Funding working capital requirements
- Business expansion and capacity enhancement
- Research and development initiatives
- General corporate purposes